FCPA Compliance & Enforcement for the Life Sciences Industry
Across the industry, from small biotechnology innovators to major multinational pharmaceutical corporations, life sciences companies rely on our prominent Life Sciences Foreign Corrupt Practice Act (FCPA) team to navigate the complex regulatory and enforcement environment that affects their operations across borders.
Our Life Sciences FCPA team is uniquely positioned to provide end-to-end support for our clients, from compliance counseling and program build-outs, to the efficient conduct of global internal investigations, and defense of companies before U.S. and international authorities, while keeping an appropriate eye towards the increasing risk of follow-on civil litigation.
As one of the few firms that regularly appears before the DOJ and SEC to handle FCPA-related investigations for life sciences companies, we support our clients with deep industry-specific expertise as they face these investigations, as well as help them implement post-resolution compliance responsibilities and monitorships.
Our Extensive Industry Experience
With a premier life sciences client portfolio and a proven record of success, we stand out for our practice's depth and breadth representing clients in FCPA investigations and related issues throughout world.
Represented three of the world’s top 10 pharmaceutical companies in the successful resolution of their DOJ/SEC FCPA matters and subsequent monitorships.
Advise life sciences clients on multifaceted government compliance, investigations and enforcement issues in over 50 countries.
Advised on the most FCPA settlements since late 2008, and more FCPA monitorships than any other firm since 2004
Represent more than half of the top 50 life sciences companies by market capitalization.
Represented a leading rare disease company in a first-of-its-kind FCPA case before the DOJ and SEC.
Provided FCPA due diligence counseling to a multinational pharmaceutical company related to its US$16 billion acquisition of the vaccines business of another pharmaceutical company, divestiture of its oncology business, and a consumer healthcare joint venture.
Our Renowned Team
Our global Life Sciences FCPA team is comprised of former government regulators and former in-house counsel from some of the world’s most respected life sciences companies. Our team leverages their significant experience to provide practical solutions to the complex challenges that arise with FCPA investigations for our life sciences clients.
Most Impressive Investigations Practice of the Year, noted for strength in the Life Sciences industry
GIR Publication, “Just Anticorruption”
Life Sciences Practice Group of the Year
Winner of Four Life Sciences Awards
LMG Life Sciences
Ranked Band 1 for FCPA
Firm of the Year – Healthcare & Life Sciences (International)
China Law & Practice
Practice Group Chair Named a “Life Sciences Trailblazer”
The National Law Journal